Joakim Wijkstrom is CMO & VP at Vanda Pharmaceuticals Inc. (VNDA). They have made 9 open-market trades across 1 company since 2020, most recently 2026-03-02.
CIK 0001785888
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VNDA | 333,469 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-03-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2026-03-02 | 2026-03-04 | $8.27 | $255K | +5.8% | -16.4% | -26.6% |
| VNDA | SELL | 2024-03-04 | 2024-03-06 | $4.30 | $72K | -4.6% | +22.6% | +28.0% |
| VNDA | SELL | 2023-08-21 | 2023-08-23 | $5.84 | $22K | -24.2% | -23.7% | -41.6% |
| VNDA | SELL | 2023-03-02 | 2023-03-06 | $6.26 | $74K | +1.3% | +7.3% | -3.0% |
| VNDA | SELL | 2022-08-22 | 2022-08-23 | $10.27 | $37K | +0.8% | -5.8% | +2.0% |
| VNDA | SELL | 2022-03-02 | 2022-03-02 | $11.19 | $156K | -0.8% | +6.1% | -11.8% |
| VNDA | SELL | 2021-08-20 | 2021-08-23 | $15.39 | $112K | +3.5% | +4.1% | +7.1% |
| VNDA | SELL | 2021-03-02 | 2021-03-03 | $18.45 | $143K | +0.3% | -10.6% | +0.6% |
| VNDA | SELL | 2020-08-20 | 2020-08-21 | $11.08 | $41K | -2.0% | -12.4% | +17.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.